Abstract
The microcirculation both responds and contributes to an inflammatory response. The inflammatory bowel diseases (IBD) provide a useful example of the profound reactivity of all segments (arterioles, capillaries, venules) of the microvasculature to inflammation, and illustrate how changes in microvascular function can influence the intensity and progression of disease activity. This chapter describes the key alterations in gut microvascular function that accompany human and experimental IBD, and addresses the prevailing views on the cellular and molecular mechanisms that underlie the altered vascular function. Impaired blood flow regulation (impaired vasomotor function), an increased adhesion of leukocytes and platelets to the vessel wall, activation of the coagulation cascade, enhanced thrombus formation, increased vascular permeability, and an accelerated rate of vascular proliferation (angiogenesis) are characteristic features of the phenotypic changes that occur in the gut vasculature during inflammation. These changes have been linked to the activation of cells that normally circulate in blood (leukocytes, platelets) or reside in the vessel wall (endothelial cells, vascular smooth muscle) or in the perivascular space (macrophages, mast cells). The chemical messengers elaborated from these activated cells stimulate different signaling pathways that ultimately elicit the phenotypic microvascular responses that accompany inflammation. Pharmacological interventions directed towards preventing some of the microvascular alterations in inflammation (e.g., angiogenesis) provide novel and potentially effective targets for treatment of IBD.
D. Neil Granger and Norman R. Harris are supported by a grant from the National Institutes of Diabetes and Digestive and Kidney Diseases (P01 DK43785-19).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Laroux FS, Grisham MB. Immunological basis of inflammatory bowel disease: role of the microcirculation. Microcirculation. 2001;8(5):283–301.
Hatoum OA, Binion DG. The vasculature and inflammatory bowel disease: contribution to pathogenesis and clinical pathology. Inflamm Bowel Dis. 2005;11(3):304–13.
Yoshida H, Granger DN. Inflammatory bowel disease: a paradigm for the link between coagulation and inflammation. Inflamm Bowel Dis. 2009;15(8):1245–55.
Alexander JS, Chaitanya GV, Grisham MB, Boktor M. Emerging roles of lymphatics in inflammatory bowel disease. Ann N Y Acad Sci. 2010;1207 Suppl 1:E75–85.
Hulten L, Lindhagen J, Lundgren O, Fasth S, Ahren C. Regional intestinal blood flow in ulcerative colitis and Crohn’s disease. Gastroenterology. 1977;72:388–96.
Harris NR, Carter PR, Lee S, Watts MN, Zhang S, Grisham MB. Association between blood flow and inflammatory state in a T-cell transfer model of inflammatory bowel disease in mice. Inflamm Bowel Dis. 2010;16:776–82.
Mori M, Stokes KY, Vowinkel T, Watanabe N, Elrod JW, Harris NR. Colonic blood flow responses in experimental colitis: time course and underlying mechanisms. Am J Physiol Gastrointest Liver Physiol. 2005;289:G1024–9.
Chidlow Jr JH, Langston W, Greer JJ, Ostanin D, Abdelbaqi M, Houghton J. Differential angiogenic regulation of experimental colitis. Am J Pathol. 2006;169:2014–30.
Harris NR, Whatley JR, Carter PR, Morgan GA, Grisham MB. Altered microvascular hemodynamics during the induction and perpetuation of chronic gut inflammation. Am J Physiol Gastrointest Liver Physiol. 2009;296:G750–4.
Lee S, Carter PR, Watts MN, Bao JR, Harris NR. Effects of the endothelin-converting enzyme inhibitor SM-19712 in a mouse model of dextran sodium sulfate-induced colitis. Inflamm Bowel Dis. 2009;15:1007–13.
Harris NR, Carter PR, Yadav AS, Watts MN, Zhang S, Kosloski-Davidson M, et al. Relationship between inflammation and tissue hypoxia in a mouse model of chronic colitis. Inflamm Bowel Dis. 2011;17:742–6.
Sasaki T, Kunisaki R, Kinoshita H, Kimura H, Kodera T, Nozawa A, et al. Doppler ultrasound findings correlate with tissue vascularity and inflammation in surgical pathology specimens from patients with small intestinal Crohn’s disease. BMC Res Notes. 2014;7:363.
Harris NR, Carter PR, Watts MN, Zhang S, Kosloski-Davidson M, Grisham MB, et al. Relationship among circulating leukocytes, platelets, and microvascular responses during induction of chronic colitis. Pathophysiology. 2011;18:305–11.
Hatoum OA, Binion DG, Otterson MF, Gutterman DD. Acquired microvascular dysfunction in inflammatory bowel disease: loss of nitric oxide-mediated vasodilation. Gastroenterology. 2003;125:58–69.
Neill LA, Saundry CM, Hyman NH, Wellman GC. Evidence against a systemic arterial defect in patients with inflammatory bowel disease. J Surg Res. 2014;191:318–22.
Leonetti D, Reimund JM, Tesse A, Viennot S, Martinez MC, Bretagne AL, et al. Circulating microparticles from Crohn’s disease patients cause endothelial and vascular dysfunctions. PLoS One. 2013;8:e73088.
Grisham MB, Kevil CG, Harris NR, Granger DN. Role of the microcirculation in chronic gut inflammation. In: Targan SR, Shanahan F, Karp LC, editors. Inflammatory bowel disease: translating basic science into clinical practice. Oxford: Blackwell Publishing; 2010. p. 157–69.
Colgan SP, Taylor CT. Hypoxia: an alarm signal during intestinal inflammation. Nat Rev Gastroenterol Hepatol. 2010;7:281–7.
Panés J, Granger DN. Leukocyte-endothelial cell interactions: molecular mechanisms and implications in gastrointestinal disease. Gastroenterology. 1998;114(5):1066–90.
Granger DN, Senchenkova E. Inflammation and the microcirculation. In: Granger DN, Granger JP, editors. Integrated systems physiology: from cell to function. Morgan & Claypool; 2010. ISBN: 9781615041657
Granger DN, Kubes P. The microcirculation and inflammation: modulation of leukocyte-endothelial cell adhesion. J Leukoc Biol. 1994;55(5):662–75.
Tailor A, Cooper D, Granger DN. Platelet-vessel wall interactions in the microcirculation. Microcirculation. 2005;12(3):275–85.
Vowinkel T, Wood KC, Stokes KY, Russell J, Tailor A, Anthoni C, et al. Mechanisms of platelet and leukocyte recruitment in experimental colitis. Am J Physiol Gastrointest Liver Physiol. 2007;293(5):G1054–60.
Suzuki K, Sugimura K, Hasegawa K, Yoshida K, Suzuki A, Ishizuka K, et al. Activated platelets in ulcerative colitis enhance the production of reactive oxygen species by polymorphonuclear leukocytes. Scand J Gastroenterol. 2001;36(12):1301–6.
Larsen TB, Nielsen JN, Fredholm L, Lund ED, Brandslund I, Munkholm P, et al. Platelets and anticoagulant capacity in patients with inflammatory bowel disease. Pathophysiol Haemost Thromb. 2002;32:92–6.
Collins CE, Rampton DS. Platelets dysfunction: a new dimension in inflammatory bowel disease. Gut. 1995;36:5–8.
Collins CE, Rampton DS. Review article: platelets in inflammatory bowel disease—pathogenetic role and therapeutic implications. Aliment Pharmacol Ther. 1997;11:237–47.
Webberley MJ, Hart MT, Melikian V. Thromboembolism in inflammatory bowel disease: role of platelets. Gut. 1993;34:247–51.
Twig G, Zandman-Goddard G, Szyper-Kravitz M, Shoenfeld Y. Systemic thromboembolism in inflammatory bowel disease: mechanisms and clinical applications. Ann N Y Acad Sci. 2005;1051:166–73.
Solem CA, Loftus EV, Tremaine WJ, Sandborn WJ. Venous thromboembolism in inflammatory bowel disease. Am J Gastroenterol. 2004;99:97–101.
Irving PM, Pasi KJ, Rampton DS. Thrombosis and inflammatory bowel disease. Clin Gastroenterol Hepatol. 2005;3:617–28.
Anthoni C, Russell J, Wood KC, Stokes KY, Vowinkel T, Kirchofer D, et al. Tissue factor: a mediator of inflammatory cell recruitment, tissue injury, and thrombus formation in experimental colitis. J Exp Med. 2007;204:1595–601.
Scaldaferri F, Sans M, Vetrano S, Graziani C, De Cristofaro R, Gerlitz B et al. Crucial role of the protein C pathway in governing microvascular inflammation in inflammatory bowel disease. J Clin Invest. 2007;117:1951–60.
Senchenkova EY, Komoto S, Russell J,Almeida-Paula LD, Yan LS, Zhang S et al. Interleukin-6 mediates the platelet abnormalities and thrombogenesis associated with experimental colitis. Am J Pathol. 2013;183:173–81.
Esmon CT. Inflammation and thrombosis. J Thromb Haemost. 2003;1:1343–8.
Chidlow Jr JH, Shukla D, Grisham MB, Kevil CG. Pathogenic angiogenesis in IBD and experimental colitis: new ideas and therapeutic avenues. Am J Physiol Gastrointest Liver Physiol. 2007;293(1):G5–18.
D'Alessio S, Tacconi C, Fiocchi C, Danese S. Advances in therapeutic interventions targeting the vascular and lymphatic endothelium in inflammatory bowel disease. Curr Opin Gastroenterol. 2013;29:608–13.
Becker F, Yi P, Al-Kofahi M, Ganta VC, Morris J, Alexander JS. Lymphatic dysregulation in intestinal inflammation: new insights into inflammatory bowel disease pathomechanisms. Lymphology. 2014;47:3–27.
Kim H, Kataru RP, Koh GY. Inflammation-associated lymphangiogenesis: a double-edged sword? J Clin Invest. 2014;124:936–42.
Kumar P, Shen Q, Pivetti CD, Lee ES, Wu MH, Yuan SY. Molecular mechanisms of endothelial hyperpermeability: implications in inflammation. Expert Rev Mol Med. 2009;11:e19.
Weber C, Fraemohs L, Dejana E. The role of junctional adhesion molecules in vascular inflammation. Nat Rev Immunol. 2007;7(6):467–77.
Mori M, Salter JW, Vowinkel T, Krieglstein CF, Stokes KY, Granger DN. Molecular determinants of the prothrombogenic phenotype assumed by inflamed colonic venules. Am J Physiol Gastrointest Liver Physiol. 2005;288(5):G920–6.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Granger, D.N., Harris, N.R. (2017). Vascular Responses to Intestinal Inflammation. In: Baumgart, D. (eds) Crohn's Disease and Ulcerative Colitis. Springer, Cham. https://doi.org/10.1007/978-3-319-33703-6_6
Download citation
DOI: https://doi.org/10.1007/978-3-319-33703-6_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-33701-2
Online ISBN: 978-3-319-33703-6
eBook Packages: MedicineMedicine (R0)